- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
David Hoyt, MD, FACS, Describes the 4 Pillars of ACS' Quality Improvement Programs
David Hoyt, MD, FACS, executive director, American College of Surgeons (ACS), says the 4 pillars are based on 100 years of setting standards for healthcare.
David Hoyt, MD, FACS, executive director, American College of Surgeons (ACS), says the 4 pillars are based on 100 years of setting standards for healthcare. He adds that ACS has programs in trauma, bariatric surgery, breast surgery, and the National Surgical Quality Improvement Program (NSQIP).
“What we’ve learned from that, is really the 4 standards or the 4 pillars of being effective,” he says.
Dr Hoyt says that first you set standards—which is done through consensus or evidence. Second, you build out the infrastructure that’s required to achieve those standards. The third pillar is to commit to measuring performance against those standards, and remain accountable to those measurements. The final pillar is agreeing to a peer review against those standards.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More
